Environmentally sustainable and climate neutral health and care systems

Closed

Code: 26862 | Identifier Code: HORIZON-HLTH-2023-CARE-04-03 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

Health and care systems are undergoing structural changes, for example by strengthening primary care and community-based care, strengthening digitalisation and making sure patients are treated or cared for at the most efficient level. This offers the possibility to connect structural changes with an environmental transformation.
Research and innovation activities under this topic should be specific to health and care sectors. They should include cost studies when relevant (environmental impacts and benefits to be quantified through the life cycle thinking approach (e.g. LCA/SLCA), to be effectively implemented in line with the European Green Deal and the Zero Pollution Action Plan) and piloting research results onsite in hospitals or other care settings while generating accessible knowledge could be included.

European Partnership on Personalised Medicine

Closed

Code: 26860 | Identifier Code: HORIZON-HLTH-2023-CARE-08-01 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

The partnership should facilitate exchange of information and good practices among countries, provide robust guidance and tools, will network institutional stakeholders and involve regional ecosystems. It should stimulate service, policy and organisational innovations, as well as the integration of biomedical and technological innovations for the benefit of the European citizens and the European industry. The partnership should bring together a broad range of actors with a common vision of future personalised medicine. Through the objectives of Horizon Europe, the partnership should contribute to achieving the following European Commission priorities:

• Promoting our European way of life
• An economy that works for people
• A Europe fit for the digital age
• A European green deal

Pandemic preparedness and response: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential

Closed

Code: 26858 | Identifier Code: HORIZON-HLTH-2023-DISEASE-03-04 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

Proposals under this topic should cover viruses for which there are no currently available effective therapeutics or for which the therapeutics available are sub-optimal, and are expected to incorporate state-of-the-art screening technology and innovative approaches to identify new targets for antiviral compound development. Emphasis should be put on the research and development of broad-spectrum antivirals, which may include repurposing of previously approved or in-pipeline drugs. Proposals could also include elucidation of mode-of-action for candidate anti-viral therapeutics.
Proposals should aim to diversify and accelerate the global therapeutic research and development pipeline for emerging and re-emerging viral infections, and to strengthen the current leading role of the EU in therapeutic research and development.

Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential

Closed

Code: 26856 | Identifier Code: HORIZON-HLTH-2023-DISEASE-03-18 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

Proposals under this topic should identify targets for optimal vaccine design for those pathogens where information on host-pathogen interaction and viral surface structures is already available. It is necessary to determine the extent of genetic variation with a view to develop vaccines with variant efficacy. In addition, it is necessary to develop animal and alternative models for the testing of vaccine candidates and for the kinetics, strength, breadth and persistence of the immune response. Proposals should focus on the following viruses: Hendra and Nipah Virus, Lassa virus, Crimean Congo haemorrhagic fever virus, Rift Valley fever virus, Ebola and Marburg virus, Dengue virus, Yellow Fever virus, Zika virus, West Nile fever virus and Chikungunya virus.

Planetary health: understanding the links between environmental degradation and health impacts

Closed

Code: 26854 | Identifier Code: HORIZON-HLTH-2023-ENVHLTH-02-01 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

Planetary health is a concept focused on the interdependencies between human health and the state of earth’s complex natural systems. A key focus is on understanding how the current trend of human-related environmental degradation can affect the health and well-being of current and future generations.
Applicants under this topic are invited to submit proposals providing actionable evidence for policymakers to take preventive actions to protect the human health and wellbeing by exploring the links between human health and environmental degradation in an integrated and comprehensive manner.

Expanding the European Electronic Health Record exchange Format to improve interoperability within the European Health Data Space

Closed

Code: 26852 | Identifier Code: HORIZON-HLTH-2023-IND-06-02 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

Electronic Health Record (EHR) interoperability has yet to become a reality in a number of use cases and health information domains. It is a complex, multi-dimensional challenge. EHRs across the Member States are diverse; so are languages, cultures, and practices in the health sector. Different technical specifications, technologies and clinical terminologies are used, involving a range of stakeholders, within and across care settings.

The Silver Deal – Person-centred health and care in European regions

Closed

Code: 26847 | Identifier Code: HORIZON-HLTH-2023-STAYHLTH-01-01 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

This topic aims to implement strategies and actions in line with the Green Paper on Ageing, the EU Long-term care report, the ‘Healthier Together’ – EU Non-Communicable Diseases Initiative, the new EU Care Strategy, which strive to address demographic change and enable better health and care for Europe’s growing ageing societies, as well as to harness the potential of the Silver Economy. NCD prevention is highly relevant to reduce the need for long-term care. New tools and integrated care models are needed, reinforcing primary, community- and home-based health and long-term care provision, through better early detection and management of diseases among older people in an increasingly ageing society and overburdened health and care systems.

Mapping the hurdles for the clinical applications of Advanced Therapy Medicinal Products (ATMPs)

Closed

Code: 26845 | Identifier Code: HORIZON-HLTH-2023-IND-06-05 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

New pioneering treatments called Advanced Therapy Medicinal Products (ATMPs), including cell and gene therapies, have the potential to bring new cures to patients affected by diseases with limited or no available treatments. However, several hurdles impede or slow down the access of ATMPs to patients in the EU and Associated Countries. These include e.g. regulatory challenges, underlying scientific uncertainties, differences in assessing the values of ATMPs by the various Health Technology Agencies (HTA), difficulties to perform randomised-controlled clinical trials or to obtain long-term safety and effectiveness data, the lack of harmonised approaches to the reimbursement of the high upfront costs by health systems, manufacturing processes, etc.

Integrated, multi-scale computational models of patient patho-physiology (‘virtual twins’) for personalised disease management

Closed

Code: 26842 | Identifier Code: HORIZON-HLTH-2023-TOOL-05-03 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

This topic will contribute to the consolidation of existing virtual twin models and support research to move towards a more integrated human virtual twin, with the aim to accelerate translational research towards cost-effective development of new health technologies. Furthermore, ‘virtual twin’ patient models hold the potential of transforming clinical processes and healthcare with longitudinal monitoring, making personalised medicine, disease prevention and individualised patient management a reality.

Supporting the uptake of innovative Health Technology Assessment (HTA) methodology and advancing HTA expertise across EU

Closed

Code: 26839 | Identifier Code: HORIZON-HLTH-2023-IND-06-01 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

HTA bodies have the responsibility to assess the added value of new health technologies and advise on its reimbursement and use within a healthcare system. Due to the rapid pace at which technology advance and in order to support decision making in an appropriate manner, HTA experts have to adapt/revise regularly their methodology. Whilst EU-funded projects in the field of HTA have addressed some of the research needs of the HTA bodies (e.g. methods of analysis, use of real-world data, use of patient reported outcomes), translation of their results/recommendations into HTA work remains limited.
Τhis action could represent an excellent opportunity for both those generating and those using the evidence to come together and discuss the key HTA methodological issues.
Τhe Coordination Group on HTA will have to adopt methodological guidelines for joint HTA work (e.g. joint clinical assessments, joint scientific consultation).

Relationship between infections and non-communicable diseases

Closed

Code: 26836 | Identifier Code: HORIZON-HLTH-2023-DISEASE-03-07 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

Proposals under this topic are expected to elucidate and provide a better understanding of causative links between infections and non-communicable diseases onsets, and/or the impact of infections on the exacerbation of existing NCDs or vice versa, in children and/or adults. The analysis of genetics, immune status, immune or inflammatory responses, microbiome, lifestyle and/or other relevant factors (e.g. differences in age, sex/gender, vaccination status, ethnicity) should be integrated to get information for prevention, early diagnosis, risk factors, and to better understand causative links as well as the progression of those non-communicable diseases.

Global coordination of exposome research

Closed

Code: 26834 | Identifier Code: HORIZON-HLTH-2023-ENVHLTH-02-04 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

The concept of the exposome refers to the totality of environmental exposures from conception onwards, including its external (e.g. diet, lifestyle, occupational and environmental factors) and internal components (e.g. epigenomics, metabolomics).Developing a comprehensive Human Exposome Project would present a fundamental shift in looking at health, by moving research away from ‘one exposure, one disease’ understanding to a more complex picture upon which to build solid, cost-effective preventive actions and policies.
The network of projects aims to study the combination of exposures to pollutants and other stressors, across different life stages and socio-economic conditions, via a number of exposure vehicles such as consumption patterns, lifestyle and working and living environment, and their collective effect on human health.

Modelling and simulation to address regulatory needs in the development of orphan and paediatric medicines

Closed

Code: 26832 | Identifier Code: HORIZON-HLTH-2023-IND-06-04 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

The topic will support research and innovation activities focusing on the development of diverse modelling and simulation methods, as tools for addressing some of the regulatory needs in the clinical development cycle of new orphan and paediatric medicinal products. The topic is not intended to implement new preclinical/clinical studies but to use the existing knowledge/data for assessing and optimising the performance of mature in-silico models in the regulatory context with the goal of improving the clinical trial designs for small populations. Availability of the relevant data to address the requirements of the topic is an indispensable condition that must be demonstrated at the proposal submission.
SME(s) participation is encouraged with the aim to strengthen their scientific and technological basis.

Addressing poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients.

Closed

Code: 26830 | Identifier Code: HORIZON-MISS-2023-CANCER-01-01 | Programme name: 2939 | Sub-program: Missions | Start submission calls: 12/01/2023 | End submission calls: 12/04/2023

This topic will contribute to the achievement of the Mission’s objective to better understand cancer by studying tumour-host interactions underpinning the development and progression of cancer, including in advanced localised or metastatic disease. The focus should be on poorly-understood cancers and their subtypes in children, adolescents, adults and the elderly.

Enhance primary cancer prevention through sustainable behavioural change

Closed

Code: 26828 | Identifier Code: HORIZON-MISS-2023-CANCER-01-02 | Programme name: 2939 | Sub-program: Missions | Start submission calls: 12/01/2023 | End submission calls: 12/04/2023

The Mission on Cancer and Europe’s Beating Cancer Plan aim to exploit the potential of primary cancer prevention by addressing key risk factors and health determinants.
Achieving sustainable behavioural change can play a major role in enhancing the impact of health promotion and preventive measures.
The uptake of policymakers across the EU to effectively change behaviour needs to be enhanced. It is also required a systemic approach involving all the main actors at different levels who can facilitate sustainable behavioural change including public authorities, policymakers, health care providers, employers, educational institutions, industry, non-governmental consumer and patient organisations, citizens and media. Also, investments are needed to establish, scale-up or improve health promotion and cancer prevention programmes through increased awareness among citizens about cancer risk factors and related behavioural change, with a focus on hard-to-reach and vulnerable groups of the population.

Pandemic preparedness and response: In vitro diagnostic devices to tackle cross-border health threats

Closed

Code: 26822 | Identifier Code: HORIZON-HLTH-2023-TOOL-05-08 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 12/01/2023 | End submission calls: 13/04/2023

Proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:

• The scientific and clinical communities, including health care providers and payers, as well as regulators, health systems and patients benefit from innovative diagnostic solutions that are better suited to tackle cross-border health threats.
• The scientific and clinical communities have access to novel and improved methodologies for detection of pathogens with pandemic potential in humans and for timely discovery of other health threats, such as chemical, radiological and nuclear threats, including considerations on detection in animals and environmental conditions.
• A diverse and robust pipeline of in vitro diagnostics is available, increasing options for clinical deployment in case of an epidemic or pandemic.

Πρόσκληση Υποβολής Προτάσεων του Προγράμματος «Ευρωπαϊκές Συμπράξεις (PRIMA)» P2P/PRIMA/0123

Closed

Code: 26817 | Identifier Code: P2P/PRIMA/0123 | Programme name: 1792 | Sub-program: i. ΠΡΟΓΡΑΜΜΑΤΑ “RESTART 2016-2020” | Start submission calls: 26/01/2023 | End submission calls: 29/03/2023

Το Πρόγραμμα «Ευρωπαϊκές Πρωτοβουλίες – Τοπική Ανάπτυξη» στοχεύει στην ενίσχυση της εξωστρέφειας του εθνικού συστήματος Έρευνας, Τεχνολογικής Ανάπτυξης και Καινοτομίας (ΕΤΑΚ) η οποία αποτελεί μία από τις οριζόντιες προτεραιότητες της Στρατηγικής Έξυπνης Εξειδίκευσης για την Κύπρο (S3Cy).

Η Κύπρος, μέσω του ΙδΕΚ, συμμετέχει σε μία σειρά από ευρωπαϊκές πρωτοβουλίες (Πρωτοβουλίες Κοινού Προγραμματισμού, Σχέδια ERANET COFUND και Προγράμματα κάτω από το Άρθρο 185 της Συνθήκης της Ευρωπαϊκής Ένωσης), οι οποίες αποσκοπούν στο συντονισμό της χρηματοδότησης της ερευνητικής δραστηριότητας και στη θέσπιση ερευνητικών προτεραιοτήτων σε πανευρωπαϊκό επίπεδο, μέσα από τη διαμόρφωση και υλοποίηση Κοινών Ερευνητικών Προγραμμάτων.

Το Πρόγραμμα «Ευρωπαϊκές Πρωτοβουλίες – Τοπική Ανάπτυξη» αποτελεί το θεσμικό πλαίσιο ανακοίνωσης των Διεθνικών Προσκλήσεων Υποβολής Προτάσεων των Ευρωπαϊκών Πρωτοβουλιών που συμμετέχει το ΙδΕΚ των οποίων το περιεχόμενο σχετίζεται με τους τομείς προτεραιότητας της S3Cy.

Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions

Closed

Code: 26810 | Identifier Code: HORIZON-MISS-2023-CANCER-01-04 | Programme name: 2939 | Sub-program: Missions | Start submission calls: 12/01/2023 | End submission calls: 12/04/2023

Best practices and tools to improve the quality of life for survivors of childhood cancer exist at national, regional and local level. These practices and tools should be scaled up or deployed in regions in at least three different Member States or Associated Countries in order to serve as demonstrators for wider uptake.
Proposals under this topic should aim to deliver results that should contribute to all of the following expected outcomes:

• Childhood cancer patients, survivors and their families benefit from enhanced quality of life through better supportive care, personalised counselling approaches, and digital tools that are accessible and affordable. Consequently, they can better achieve their values and personal life goals.
• Health care professionals, supportive workers and councillors enhance the quality of life for childhood cancer patients, survivors and their families.

Scheme E-Mobility Promotion Plan in Cyprus – 2nd announcement December 2022

Closed

Code: 26759 | Identifier Code: C2.2I3 | Programme name: 13600 | Start submission calls: 09/01/2023 | End submission calls: 09/03/2023

The Plan concerns the implementation of two interventions of measure C2.2I3 of the SAA, the first of which aims at the Withdrawal of Polluting Vehicles and the Granting of Incentives for Alternative, Low Emission, Transport Modes (intervention C2.2I3c of the SAA) and the second at the Subsidy for Electric Vehicle Market (C2.2I3b intervention in the SAA).

Call Closing Date: 9 March 2023 at 11:00am

Incentive Scheme for Work Rehabilitation of Released Persons

Closed

Code: 26731 | Programme name: 2799 | Start submission calls: 23/10/2020 | End submission calls: 31/12/2024

The Plan aims to facilitate the social reintegration and work rehabilitation of persons who have been released from the Central Prisons of the Republic of Cyprus by providing incentives to employers to hire them.